Low temperature neutron diffraction studies in [Mn3(suc)2(ina)2]n: an homometallic molecular 3D ferrimagnet

Neutron diffraction techniques have been used to determine the low temperature crystal structure and to shed light on the magnetic behavior of the [Mn(3)(suc)(2)(ina)(2)](n) (suc = succinate and ina = isonicotinate) complex. The ferromagnetic signal observed below T(c) ≈ 5 K in this compound is due to a noncompensation of homometallic spins in the 3D framework. The Mn(II) magnetic moments obtained from neutron diffraction refinements are slightly lower than those observed for isolated Mn(II) ions; this can be due to covalent spin delocalization or geometrical magnetic fluctuations. A small discrepancy between the value of the magnetic moments of each Mn(II) site is also observed [Mn(1) 4.1(2) μ(B) and the Mn(2) 3.9(1) μ(B)]. These differences between the theoretical and observed manganese magnetic moments are not unexpected in this large spin metal complex, and qualitatively reasonable given the synergistic interaction between the metal ions through oxo-bridge. The competition among different interactions, principally those covalent through organic ligands and dipolar interaction, drive to a final 3D ferrimagnetic order.     

Environment-Sensitive Fluorescence of 7-Nitrobenz-2-oxa-1,3-diazol-4-yl (NBD)-Labeled Ligands for Serotonin Receptors

Serotonin is a neurotransmitter that plays a crucial role in the regulation of several behavioral and cognitive functions by binding to a number of different serotonin receptors present on the cell surface. We report here the synthesis and characterization of several novel fluorescent analogs of serotonin in which the fluorescent NBD (7-nitrobenz-2-oxa-1,3-diazol-4-yl) group is covalently attached to serotonin. The fluorescent ligands compete with the serotonin_1A receptor specific radiolabeled agonist for binding to the receptor. Interestingly, these fluorescent ligands display a high environmental sensitivity of their fluorescence. Importantly, the human serotonin_1A receptor stably expressed in CHO-K1 cells could be specifically labeled with one of the fluorescent ligands with minimal nonspecific labeling. Interestingly, we show by spectral imaging that the NBD-labeled ligand exhibits a red edge excitation shift (REES) of 29 nm when bound to the receptor, implying that it is localized in a restricted microenvironment. Taken together, our results show that NBD-labeled serotonin analogs offer an attractive fluorescent approach for elucidating the molecular environment of the serotonin binding site in serotonin receptors. In view of the multiple roles played by the serotonergic systems in the central and peripheral nervous systems, these fluorescent ligands would be useful in future studies involving serotonin receptors.     

Pharmacological characterization of ligands at recombinant NMDA receptor subtypes by electrophysiological recordings and intracellular calcium measurements

Generation of in vitro cellular assays using fluorescence measurements at heterologously expressed NMDA receptors would speed up the process of ligand characterization and enable high-throughput screening. The major drawback to the development of such assays is the cytotoxicity caused by Ca(2+)-flux into the cell via NMDA receptors upon prolonged activation by agonists present in the culture medium. In the present study, we established four cell lines with stable expression of NMDA receptor subtypes NR1/NR2A, NR1/NR2B, NR1/NR2C, or NR1/NR2D in BHK-21 cells. To assess the usefulness of the stable cell lines in conjunction with intracellular calcium ([Ca(2+)](i)) measurements for evaluation of NMDA receptor pharmacology, several ligands were characterized using this method. The results were compared to parallel data obtained by electrophysiological recordings at NMDA receptors expressed in Xenopus oocytes. This comparison showed that agonist potencies determined by [Ca(2+)](i) measurements and electrophysiological recordings correlated well, meaning that the stable cell lines in conjunction with [Ca(2+)](i) measurements provide a useful tool for characterization of NMDA receptor ligands. The agonist series of conformationally constrained glutamate analogues (2S,3R,4S)-alpha-(carboxycyclopropyl)glycine (CCG), 1-aminocyclobutane-r-1,cis-3-dicarboxylic acid (trans-ACBD), and (+/-)-1-aminocyclopentane-r-1,cis-3-dicarboxylic acid (cis-ACPD), as well as the highly potent agonist tetrazolylglycine were among the characterized ligands that were assessed with respect to subtype selectivity at NMDA receptors. However, none of the characterized agonists displays more than 2-3 fold selectivity towards a specific NMDA receptor subtype. Thus, the present study provides a broad pharmacological characterization of structurally diverse ligands at recombinant NMDA receptor subtypes.     

Affinity-guided protein conjugation: the trilogy of covalent protein labeling,assembly and inhibition

Specific and dynamic biological interactions pave the blueprint of signal networks in cell. For example, a great variety of specific protein-ligand interactions define how intracellular signals flow. Taking advantage of the specificity of these interactions, we postulate an “affinity-guided covalent conjugation” strategy to lock binding ligands through covalent reactions between the ligand and the receptor protein. The presence of a nucleophile close to the ligand binding site of a protein is sine qua none of this reaction. Specific noncovalent interaction of a ligand derivative (which contains an electrophile at a designed position) to the ligand binding site of the protein brings the electrophile to the close proximity of the nucleophile. Subsequently, a conjugation reaction spontaneously takes place between the nucleophile and the electrophile, and leads to an intermolecular covalent linkage. This strategy was first showcased in coiled coil peptides which include a cysteine mutation at a selected position. The short peptide sequence was used for covalent labeling of cell surface receptors. The same strategy was then used to guide the design of a set of protein Lego bricks for covalent assembly of protein complexes of unnatural geometry. We finally made “reactive peptides” for natural adaptor proteins that play significant roles in signal transduction. The peptides were designed to react with a single domain of the multidomain adaptor protein, delivered into the cytosol of neurons, and re-directed the intracellular signal of neuronal migration. The trilogy of protein labeling, assembly, and inhibition of intracellular signals, all through a specific covalent bond, fully demonstrated the generality and versatility of “affinity-guided covalent conjugation” in various applications.     

Transformation of Receptor Tyrosine Kinases into Glutamate Receptors and Photoreceptors

Receptor tyrosine kinases (RTKs) are key regulators of cellular functions in metazoans. In vertebrates, RTKs are mostly activated by polypeptides but are not naturally sensitive to amino acids or light. Taking inspiration from Venus kinase receptors (VKRs), an atypical family of RTKs found in nature, we have transformed the human insulin (hIR) and hepatocyte growth factor receptor (hMET) into glutamate receptors by replacing their extracellular binding domains with the ligand‐binding domain of metabotropic glutamate receptor type 2 (mGluR2). We then imparted light sensitivity through covalent attachment of a synthetic glutamate‐based photoswitch via a self‐labelling SNAP tag. By employing a Xenopus laevis oocyte kinase activity assay, we demonstrate how these chimeric RTKs, termed light‐controlled human insulin receptor (LihIR) and light‐controlled human MET receptor (LihMET), can be used to exert optical control over the insulin or MET signaling pathways. Our results outline a potentially general strategy to convert RTKs into photoreceptors.     

Silent, fluorescent labeling of native neuronal receptors

We have developed a minimally-perturbing strategy that enables labeling and subcellular visualization of endogenous dendritic receptors on live, wild-type neurons. Specifically, calcium-permeable non-NMDA glutamate receptors expressed in hippocampal neurons can be targeted with this novel synthetic tri-functional molecule. This ligand-directed probe was targeted towards AMPA receptors and bears an electrophilic group for covalent bond formation with an amino acid side chain on the extracellular side of the ion channel. This molecule was designed in such a way that the use-dependent, polyamine-based ligand accumulates the chemically-reactive group at the extracellular side of these polyamine-sensitive receptors, thereby allowing covalent bond formation between an electrophilic moiety on the nanoprobe and a nucleophilic amino acid sidechain on the receptor. Bioconjugation of this molecule results in a stable covalent bond between the nanoprobe and the target receptor. Subsequent photolysis of a portion of the nanoprobe may then be employed to effect ligand release allowing the receptor to re-enter the non-liganded state, all the while retaining the fluorescent beacon for visualization. This technology allows for rapid fluorescent labeling of native polyamine-sensitive receptors and further advances the field of fluorescent labeling of native biological molecules.     

Temperature dependence of the crystal lattice organization of coordination compounds involving nitronyl nitroxide radicals: a magnetic and structural investigation

Four new mononuclear complexes of formula Cd(PN)(4)(NCS)(2) (A), Cd(PNN)(4)(N(3))(2) (B), Zn(PNN)(4)(N(3))(2) (C), and Zn(PNN)(2)(NCS)(2) (D), where PNN stands for 2-(4-pyridyl)-4,4,5,5-tetramethylimidazoline-1-oxyl-3-oxide and PN for 2-(4-pyridyl)-4,4,5,5-tetramethylimidazoline-1-oxyl, were synthesized and structurally and magnetically characterized. The X-ray structures of compounds B and C were also determined at 90 K. Compounds A[bond]C crystallize in the triclinic space group P 1 macro (No. 2), and D crystallizes in the monoclinic space group P2(1)/m (No. 11). A[bond]C adopt a centrosymmetric distorted octahedral geometry in which the metal ions are bonded to four radical ligands through the nitrogen atom of the pyridyl rings and the azido or thiocyanato ligands occupy the apical positions. Compound D adopts a distorted tetrahedral geometry in which the zinc ion is bonded to two radicals and two thiocyanato ligands. As suggested by their magnetic behavior, the low-temperature X-ray structures of B and C show that these compounds undergo a clear structural change with respect to the room-temperature structures. The experimental magnetic behaviors were perfectly reproduced by a dimer model for A[bond]C and an alternating chain model for D while the sudden breaks observed in the chi(M)T versus T curves for B and C were well accounted for by the high- and low-temperature X-ray structures. For all these complexes the crystal structures favor significant overlap between molecular magnetic orbitals leading to rather strong intermolecular antiferromagnetic interactions.     

The all non-metal homodinuclear and heterodinuclear sandwich-like compounds C2(η3-L3)2 and BN(η3-L3)2 (L = BCO, BNN and CBO)

Density functional theory studies on the all non-metal homodinuclear and heterodinuclear sandwich-like compounds C(2)(η(3)-L(3))(2) and BN(η(3)-L(3))(2) (L = BCO, BNN and CBO) have been performed. The staggered conformations of both C(2)(η(3)-L(3))(2) and BN(η(3)-L(3))(2) are predicted to be stable. The non-metal direct C-C and B-N bonds are covalent with σ interactions, which are formed by the interactions of s and p(z) orbitals of the center atoms. Different from the ionic metal-ligand bond in the traditional metal center sandwich-like compounds, the C-L, B-L, and N-L bonds are covalent in these all non-metal sandwich-like compounds. The NICS values indicate that the ligands of C(2)(η(3)-L(3))(2) and BN(η(3)-L(3))(2), as well as their bare rings, display multiple aromaticity (σ and π aromaticity). Both σ and π aromaticity of the ring ligands towards the center atoms become stronger after complexation with the center atoms, while the π aromaticity against the center atoms is reduced. The π aromaticity of the ligands bonded to different center atoms follows a trend of B > C > N, and the (CBO)(3)(+) ligands bonded to B possess the strongest π aromaticity. The dissociation reactions and possible synthetic reactions analysis show that these all non-metal sandwich-like compounds are stable, and the homodinuclear species are more stable than the heterodinuclear ones. These all non-metal binuclear sandwich-like compounds can be regarded as potential synthetic targets according to the highly negative free energies of the possible synthetic reactions. The isomerization reactions demonstrate that the CBO-based compounds should be more possible to synthesize in experiments than their BCO-based isomers.     

Structure-activity relationships of GHRP-6 azapeptide ligands of the CD36 scavenger receptor by solid-phase submonomer azapeptide synthesis

The cluster of differentiation 36 (CD36) class B scavenger receptor binds a variety of biologically endogenous ligands in addition to synthetic peptides (i.e., growth hormone-releasing peptides, GHRPs), which modulate biological function related to anti-angiogenic and anti-atherosclerotic activities. Affinity labeling had previously shown that GHRP-6 analogues such as hexarelin, [2-Me-W(2)]GHRP-6 (1), bind to the lysine-rich domain of the CD36 receptor. Moreover, the azapeptide analogue [aza-F(4)]GHRP-6, 2, exhibited a characteristic β-turn conformation as described by CD and NMR spectroscopy and a slightly higher CD36 binding affinity relative to hexarelin (1.34 and 2.37 μM, respectively), suggesting receptor binding was mediated by the conformation and the aromatic residues of these peptide sequences. Ligand-receptor binding interactions were thus explored using azapeptides to examine influences of side-chain diversity and backbone conformation. In particular, considering that aromatic cation interactions may contribute to binding affinity, we have explored the potential of introducing salt bridges to furnish GHRP-6 azapeptide ligands of the CD36 receptor. Fifteen aza-glutamic acid analogues related to 2 were prepared by submonomer solid-phase synthesis. The azapeptide side chains were installed by novel approaches featuring alkylation of resin-bound semicarbazone with Michael acceptors and activated allylic acetates in the presence of phosphazene base (BTPP). Moreover, certain Michael adducts underwent intramolecular cyclization during semicarbazone deprotection, leading to novel pyrrazoline and aza-pyroglutamate N-terminal residues. Structural studies indicated that contingent on sequence the [aza-Glu]GHRP-6 analogues exhibited CD spectra characteristic of random coil, polyproline type II and β-turn secondary structures in aqueous media. In covalent competition binding studies with the GHRP-6 prototype hexarelin bearing a radiotracer, certain [aza-Glu]GHRP-6 azapeptides retained relatively high (2-27 μM) affinity for the CD36 scavenger receptor.     

Structure, bonding, electronic and energy aspects of a new family of early lanthanide (La, Ce and Nd) complexes with phosphoric triamides: insights from experimental and DFT studies

A new family of isostructural early lanthanide(III) complexes (LnXPA) of the general formula Ln(XPA)(2)Cl(3)(solv)(2), where Ln = La, Ce and Nd, XPA = (4-X-C(6)H(4)NH)P(O)(NC(4)H(8)O)(2), X = H, F, Cl and Br, and solv = H(2)O and CH(3)OH, is introduced. X-ray crystallography shows that the replacement of the coordinated water by a methanol molecule may reduce the symmetry level of the unit cell from the orthorhombic crystal system and the space group Fdd2 to monoclinic and C2/c. DFT calculations, at B3LYP, PBE and B3PW91 levels, have been carried out to get a better insight into the structural, electronic and energy aspects of the compounds. The large cation attraction energy (-ΔE) values in the range 269-273 kcal mol(-1), at the B3PW91/ECP/6-311+G** level for the model complexes XPA-La(3+) with stoichiometry 1 : 1, represent new ligands XPA as efficient complexant agents for lanthanides. The electronic nature of para substituent X has no significant effect on the Ln-ligand bonding and cation affinity of the ligands XPA. The results of atoms in molecules (AIM) analysis reveal a partial covalent contribution of the Ln-ligand interaction for the models XPA-La(3+) in the absence of counterions and coordinated solvents. In the real complexes LnXPA, a closed-shell Ln-ligand interaction is established. Increasing the charge difference between nitrogen and phosphorus atoms (by ~0.06 e) associated with a weakening of the Lp(O(P))→σ*(P-N) electronic delocalization (Lp(O(P)) being the lone pair of the phosphoryl oxygen atom) may lead to an increase in partial multiple bond character of the P-N bonds in coordinated ligands, agreeing with the increase in ν(P-N) and (2)J(PH) coupling constant values. The changes in electron density (ρ) and electronic energy density (H(r)) values confirm these structural reorganizations upon complexation.     

CB1 Cannabinoid Receptor Signaling and Biased Signaling

The CB1 cannabinoid receptor is a G-protein coupled receptor highly expressed throughout the central nervous system that is a promising target for the treatment of various disorders, including anxiety, pain, and neurodegeneration. Despite the wide therapeutic potential of CB1, the development of drug candidates is hindered by adverse effects, rapid tolerance development, and abuse potential. Ligands that produce biased signaling—the preferential activation of a signaling transducer in detriment of another—have been proposed as a strategy to dissociate therapeutic and adverse effects for a variety of G-protein coupled receptors. However, biased signaling at the CB1 receptor is poorly understood due to a lack of strongly biased agonists. Here, we review studies that have investigated the biased signaling profile of classical cannabinoid agonists and allosteric ligands, searching for a potential therapeutic advantage of CB1 biased signaling in different pathological states. Agonist and antagonist bound structures of CB1 and proposed mechanisms of action of biased allosteric modulators are used to discuss a putative molecular mechanism for CB1 receptor activation and biased signaling. Current studies suggest that allosteric binding sites on CB1 can be explored to yield biased ligands that favor or hinder conformational changes important for biased signaling.     

Crosslinking of CD38 Receptors Triggers Apoptosis of Malignant B Cells

Recently, we designed an inventive paradigm in nanomedicine—drug-free macromolecular therapeutics (DFMT). The ability of DFMT to induce apoptosis is based on biorecognition at cell surface, and crosslinking of receptors without the participation of low molecular weight drugs. The system is composed of two nanoconjugates: a bispecific engager, antibody or Fab’ fragment—morpholino oligonucleotide (MORF1) conjugate; the second nanoconjugate is a multivalent effector, human serum albumin (HSA) decorated with multiple copies of complementary MORF2. Here, we intend to demonstrate that DFMT is a platform that will be effective on other receptors than previously validated CD20. We appraised the impact of daratumumab (DARA)- and isatuximab (ISA)-based DFMT to crosslink CD38 receptors on CD38+ lymphoma (Raji, Daudi) and multiple myeloma cells (RPMI 8226, ANBL-6). The biological properties of DFMTs were determined by flow cytometry, confocal fluorescence microscopy, reactive oxygen species determination, lysosomal enlargement, homotypic cell adhesion, and the hybridization of nanoconjugates. The data revealed that the level of apoptosis induction correlated with CD38 expression, the nanoconjugates meet at the cell surface, mitochondrial signaling pathway is strongly involved, insertion of a flexible spacer in the structure of the macromolecular effector enhances apoptosis, and simultaneous crosslinking of CD38 and CD20 receptors increases apoptosis.     

Chemical cell-surface receptor engineering using affinity-guided, multivalent organocatalysts

Catalysts hold promise as tools for chemical protein modification. However, the application of catalysts or catalyst-mediated reactions to proteins has only recently begun to be addressed, mainly in in vitro systems. By radically improving the affinity-guided DMAP (4-dimethylaminopyridine) (AGD) catalysts that we previously reported (Koshi, Y.; Nakata, E.; Miyagawa, M.; Tsukiji, S.; Ogawa, T.; Hamachi, I. J. Am. Chem. Soc. 2008, 130, 245.), here we have developed a new organocatalyst-based approach that allows specific chemical acylation of a receptor protein on the surface of live cells. The catalysts consist of a set of 'multivalent' DMAP groups (the acyl transfer catalyst) fused to a ligand specific to the target protein. It was clearly demonstrated by in vitro experiments that the catalyst multivalency enables remarkable enhancement of protein acylation efficiency in the labeling of three different proteins: congerin II, a Src homology 2 (SH2) domain, and FKBP12. Using a multivalent AGD catalyst and optimized acyl donors containing a chosen probe, we successfully achieved selective chemical labeling of bradykinin B(2) receptor (B(2)R), a G-protein coupled receptor, on the live cell-surface. Furthermore, the present tool allowed us to construct a membrane protein (B(2)R)-based fluorescent biosensor, the fluorescence of which is enhanced (tuned on) in response to the antagonist ligand binding. The biosensor should be applicable to rapid and quantitative screening and assay of potent drug candidates in the cellular context. The design concept of the affinity-guided, multivalent catalysts should facilitate further development of diverse catalyst-based protein modification tools, providing new opportunities for organic chemistry in biological research.     

Gas-phase stability of derivatives of the closo-hexaborate dianion B(6)H(6)(2-)

B(6)H(6)(2-) does not represent a stable gas-phase dianion, but emits spontaneously one of its excess electrons in the gas phase. In this work we address the question whether small stable gas-phase dianions can be constructed from the parent B(6)H(6)(2-) dianion by substitution of the hydrogens with appropriate ligands. Various hexa-, tetra-, and disubstituted derivatives B(6)L(6)(2-), B(6)H(2)L(4)(2-), and B(6)H(4)L(2)(2-) (L = F, Cl, CN, NC, or BO) are investigated with ab initio methods in detail. Four stable hexasubstituted B(6)L(6)(2-) (L = Cl, CN, NC, or BO) and three stable B(6)H(2)L(4)(2-) (L = CN, NC, or BO) gas-phase dianions could be identified and predicted to be observable in the gas phase. The trends in the electron-detachment energies depending on various ligands are discussed and understood in the underlying electrostatic pattern and the electronegativities of the involved elements.     

Lead(II) thiocyanate complexes with bibracchial lariat ethers: an X-ray and DFT study

Compounds of formula [Pb(L2)(NCS)2] (1) and [Pb(L4)(SCN)2] (2) (where L2 is the lariat crown ether N,N'-bis(3-aminobenzyl)-4,13-diaza-18-crown-6 and L4 is the Schiff-base lariat crown ether N,N'-bis(3-(salicylaldimino)benzyl)-4,13-diaza-18-crown-6) were isolated and structurally characterized by X-ray diffraction analyses. The X-ray crystal structures of both compounds show the metal ion coordinated to the six donor atoms of the crown moiety, leaving the corresponding pendant arms uncoordinated. The coordination sphere of lead(II) is completed by two thiocyanate groups that coordinate either through their nitrogen (1) or sulfur (2) atoms. The organic receptor adopts a syn conformation in 1, while in 2 it shows an anti conformation. To rationalize these unexpected different conformations of the L2 and L4 receptors in compounds 1 and 2, as well as the different binding modes found for the thiocyanate ligands, we have carried out theoretical calculations at the DFT (B3LYP) level. These calculations predict the syn conformation being the most stable in both 1 and 2 complexes. So, the anti conformation found for 2 in the solid state is tentatively attributed to the presence of intermolecular pi-pi interactions between phenol rings, for which the dihedral angle between the least-squares planes of both rings amounts to 2.6 degrees and the distance between the center of both rings is 3.766 A. On the other hand, the analysis of the electronic structure has revealed that the Pb-ligand bonds present highly ionic character in this family of compounds. They also suggest a greater transfer of electron density from the NCS- ligands when they coordinate through the less electronegative S atom. The Pb-SCN covalent bond formation mainly occurs due to an effective overlap of the occupied 3p z orbitals of the S atoms and the unoccupied 6p z AO of the Pb atom, while the Pb-NCS bonding interaction is primarily due to the overlap of the 6s and 7s AO of Pb with sp(1.10) hybrids of the N donor atoms. Our electronic structure calculations can rationalize the different coordination of the thiocyanate groups in compounds 1 and 2: the simultaneous formation of two Pb-SCN bonds is more favorable for S-Pb-S angles close to 180 degrees , for which the overlap between the occupied 3p z orbitals of the S atoms and the unoccupied 6 pz AO of the Pb atom is maximized.     

"Alkaline-earth metals in a box": structures of solvent-separated ion pairs

During our research on homoleptic organocalcium compounds, we found that fluorenylcalcium complexes show unusual solution behavior and precipitate from nonpolar solvents after addition of THF. Their solid-state structures reveal the unexpected rupture of both metal-carbanion bonds by the polar solvent THF. The crystal structures of five new Mg and Ca solvent-separated ion pairs are described. The compound [Ca(2+)(thf)(6)][Me(3)Si(fluorenyl(-))](2) is the first organometallic complex of a Group 2 element that crystallizes as a completely solvent-separated ion pair. The driving forces for its formation are: 1) the strong Ca-THF bond; 2) the stability of the free [Me(3)Si(fluorenyl)](-) ion; 3) encapsulation of [Ca(2+)(thf)(6)] in a "box", the walls of which consist of anionic fluorenyl ligands and benzene molecules; and 4) the presence of numerous (THF)C- H...pi interactions. The magnesium analogue [Mg(2+)(thf)(6)][Me(3)Si(fluorenyl(-))](2) is isostructural. Bis(7,9-diphenylcyclopenta[a]acenaphthadienyl)calcium also crystallizes as a completely solvent-separated ion pair and can likewise be described as a [Ca(2+)(thf)(6)] species in a box of delocalized anions and benzene molecules. In addition, the structures of two Ph(4)B(-) complexes of Mg and Ca are described. [Mg(2+)(thf)(6)][Ph(4)B(-)](2) crystallizes as a completely solvent-separated ion pair and also shows a solvated metal cation bonded via C-H.pi interactions in a cavity formed by Ph(4)B(-) ions. [(thf)(4)CaBr(+)][Ph(4)B(-)] has a structure in which one of the anionic ligands is still bonded to the Ca atom. Bridging bromide ligands result in the formation of the dimer [(thf)(4)CaBr(+)](2).     

Crosslinking of and coupling to viral capsid proteins by tyrosine oxidation

Cowpea mosaic virus is composed of 60 identical copies of a two-subunit protein organized in pentameric assemblies around the icosahedral 5-fold symmetry axis. Treatment of the virus with the Ni(II) complex of the tripeptide GGH and a peroxide oxidant, or irradiation in the presence of Ru(bpy)(3)(2+) and persulfate generates covalent crosslinks across the pentameric subunit boundaries, effectively stitching the subunits together. Intersubunit crosslinking was found to occur exclusively at adjacent tyrosine residues (Y52-Y103), as predicted from the X-ray crystal structure of the capsid, and to be more extensive with the photochemical ruthenium system. The Ni/GGH oxidative procedure was also used to make covalent attachments to the virion by trapping with a functionalized disulfide reagent.     

Synthetic multivalent ligands as probes of signal transduction

Cell-surface receptors acquire information from the extracellular environment and coordinate intracellular responses. Many receptors do not operate as individual entities, but rather as part of dimeric or oligomeric complexes. Coupling the functions of multiple receptors may endow signaling pathways with the sensitivity and malleability required to govern cellular responses. Moreover, multireceptor signaling complexes may provide a means of spatially segregating otherwise degenerate signaling cascades. Understanding the mechanisms, extent, and consequences of receptor co-localization and interreceptor communication is critical; chemical synthesis can provide compounds to address the role of receptor assembly in signal transduction. Multivalent ligands can be generated that possess a variety of sizes, shapes, valencies, orientations, and densities of binding elements. This Review focuses on the use of synthetic multivalent ligands to characterize receptor function.     

Exchange of an imido ligand in bis(imido) complexes of uranium

Addition of B(C6H5)3.H2O to U(NtBu)2I2(THF)2 provides U(NtBu)(O)I2(THF)2, a complex with a trans arrangement of the oxo and imido ligands. A DFT study on the Ph3PO adduct, U(NtBu)(O)I2(Ph3PO)2, reveals that there are six bonding orbitals in the O=U=N interaction, much like the bis(imido) N=U=N interaction. However, the calculations suggest that the multiple bonding in the oxo imido complexes is less covalent than that in the bis(imido) analogues.     

Improvement of Targeted Gene Delivery to Human Cancer Cells by a Novel Trifunctional Crosslinker

A facile method for the construction of an immunoconjugate which displays targeting ligands, such as antibody fragments, with a high density is reported. For this purpose, we synthesized a novel trifunctional crosslinking reagent. By the use of this reagent, ligands targeting the specific cell can be displayed on the surface of the drug carrier with a high density. In this study, we display HER2 (human epidermal growth‐factor receptor‐2) binding ligands on branched polyethylenimine (PEI), which can form polyplexes with plasmid DNA. Kinetic analysis of the binding to the extracellular domain of HER2 show the PEI displaying a high density of ligands binds to the target more strongly compared to the PEI displaying ligands at a low density. The increased density of HER2 ligands displayed on the gene carrier contributes to the improved transfection efficiency. This approach can be applied to other drug delivery systems, including liposome, micelle, and so on.